Results 131 to 140 of about 15,602,619 (166)
Some of the next articles are maybe not open access.
Blood, 2006
In a recent issue of Blood, Gaines[1][1] reported on disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following intravenous administration of Rho(D) immune globulin as a treatment for immune thrombocytopenic purpura (ITP).
Joseph Schwartz +2 more
openaire +1 more source
In a recent issue of Blood, Gaines[1][1] reported on disseminated intravascular coagulation associated with acute hemoglobinemia or hemoglobinuria following intravenous administration of Rho(D) immune globulin as a treatment for immune thrombocytopenic purpura (ITP).
Joseph Schwartz +2 more
openaire +1 more source
Clinical evaluation of Rho(D) immune globulin (human) in Canada.
Canadian Medical Association journal, 1970-During 1966, clinical trials were conducted in three Canadian centres to determine the safety and efficacy of Rh(0)(D) immune globulin (human) in preventing isoimmunization by the Rh(0)(D) antigen in Rh-negative women delivering ABO-compatible Rh-positive infants.The candidates were randomly divided into control and treated groups; the treated mothers
E C, Bryant +6 more
openaire +1 more source
The Journal of reproductive medicine, 2003
To examine the practice patterns and differences between faculty members in obstetrics and gynecology (OB/G) and family practice (FP) residency programs in administering Rho(D) immune globulin (RhIG) for threatened abortion.A questionnaire was mailed to 50% (222) of all FP residencies and 100% (267) of OB/G programs in the United States.
Alicia M, Weissman +3 more
openaire +2 more sources
To examine the practice patterns and differences between faculty members in obstetrics and gynecology (OB/G) and family practice (FP) residency programs in administering Rho(D) immune globulin (RhIG) for threatened abortion.A questionnaire was mailed to 50% (222) of all FP residencies and 100% (267) of OB/G programs in the United States.
Alicia M, Weissman +3 more
openaire +2 more sources
Dermatofibrosarcoma protuberans arising at a Rho(D) immune globulin injection site.
Cutis, 2013Dermatofibrosarcoma protuberans (DFSP) is a rare soft tissue tumor arising in the dermis. It is notorious for high rates of local recurrence despite its low metastatic potential. Although the etiology is unknown, DFSP often is considered to arise within scars and at sites of prior vaccination or trauma. Clinically, DFSP can be highly variable and mimic
Stefanie A, Hirano, Cyndi M, Torosky
openaire +1 more source
Blood, 2011
Abstract Abstract 4670 BACKGROUND: Acute hemolytic reactions (AHR) associated with administration of Rho (D) Immune Globulin (RhIG; WinRho® SDF, Cangene Corporation, Winnipeg, Canada) have been infrequently reported during the previous 16 years.
Carmen Muller +3 more
openaire +1 more source
Abstract Abstract 4670 BACKGROUND: Acute hemolytic reactions (AHR) associated with administration of Rho (D) Immune Globulin (RhIG; WinRho® SDF, Cangene Corporation, Winnipeg, Canada) have been infrequently reported during the previous 16 years.
Carmen Muller +3 more
openaire +1 more source
SERUM SICKNESS REACTION FOLLOWING RHO(D) IMMUNE GLOBULIN
Annals of Allergy, Asthma & Immunology, 2023Y. Ghiasi, T. Carr
openaire +1 more source
Reduced dose of Rho(D) immune globulin following induced first-trimester abortion.
American journal of obstetrics and gynecology, 1977A double-blind study of women after first-trimester abortion supports the efficacy of low-dose Rho(D) immune globulin (human) in the prevention of Rh sensitization. Twenty-seven per cent of patients demonstrated a fetomaternal blood leak based on Kleihauer-Betke stains.
P A, Hensleigh +5 more
openaire +1 more source
The Prenatal Use Of Rho(D) Immune Globulin
MCN, The American Journal of Maternal/Child Nursing, 1984R M, Hammer, E J, Bower, L J, Messina
openaire +2 more sources
Neuro endocrinology letters, 2008
Many formulations of Thimerosal (49.55% mercury by weight)-containing Rho(D) immune globulins (TCRs) were routinely administered to Rh-negative mothers in the US prior to 2002.It was hypothesized: (1) if prenatal Rho(D)-immune globulin preparation exposure was a risk factor for neurodevelopmental disorders (NDs) then more children with NDs would have ...
David A, Geier +4 more
openaire +1 more source
Many formulations of Thimerosal (49.55% mercury by weight)-containing Rho(D) immune globulins (TCRs) were routinely administered to Rh-negative mothers in the US prior to 2002.It was hypothesized: (1) if prenatal Rho(D)-immune globulin preparation exposure was a risk factor for neurodevelopmental disorders (NDs) then more children with NDs would have ...
David A, Geier +4 more
openaire +1 more source
Hospital Pharmacy, 2001
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
openaire +1 more source
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), to discuss methods of prevention, and to promote reporting of ADRs to the FDA's medWatch program (1-800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
openaire +1 more source

